Use of omalizumab to improve desensitization safety in allergen immunotherapy

J Allergy Clin Immunol. 2014 Mar;133(3):937-937.e2. doi: 10.1016/j.jaci.2013.12.1089.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / therapy*
  • Desensitization, Immunologic*
  • Female
  • Humans
  • Omalizumab

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab